Compare Adaptive Biotechnologies Corp (ADPT) vs iShares MSCI Germany (DAX) (EWG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs iShares MSCI Germany (DAX) — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while iShares MSCI Germany (DAX) trades at $41.32. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, iShares MSCI Germany (DAX) nearer its low. Which is the better fit depends on your goals.
| ADPT | EWG | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $22.37 | $44.56 |
52-Week Low | $10.24 | $38.08 |
Enterprise Value | $3.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWG is trading at $42.66, up 0.83% with a bullish technical signal from moving averages. The stock shows strong momentum indicators but RSI suggests potential overbought conditions. Recent European market strength and German economic reforms provide positive backdrop. Dividend of $0.83 scheduled for June 2026 indicates shareholder returns commitment.
Outlook remains positive with European equity momentum and potential short-squeeze dynamics. Key risks include ECB rate hikes impacting growth sectors and German industrial employment concerns. Investment opportunity lies in European market rotation and cyclical sector strength, though valuation metrics require monitoring given limited fundamental data availability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →
